Clinical Trial Update: Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration

View source ↗

Summary

This clinical trial update describes a study to test an immune-reconstitution-based scoring system to guide the duration of letermovir prophylaxis for reducing …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cytomegalovirus Infection

Drugs mentioned

• PREVYMIS (letermovir)

Snippet

Sponsor: Institute of Hematology & Blood Diseases Hospital, China | Conditions: CMV Infection | Status: NOT_YET_RECRUITING